-transparent.png){kind=logo}
The sulfated N-terminus and the carboxyamidated C-terminus of cholecystokinin octapeptide (CCK-8) were radioimmunoassayed in cerebrospinal fluid from 19 patients with multiple sclerosis (MS) and 17 control subjects. While the N-terminal immunoreactivity was normal in all phases of MS, the concentration of C-terminal CCK immunoreactivity was significantly increased from 3.7 +/- 0.3 to 7.9 +/- 1.0 pmol/l (mean +/- S.E.M.) in both progressive and stable phases. The results indicate that C-terminal forms of CCK are released at an increased rate or that increased amounts of CCK-8 are released together with enhanced aminopeptidase activity in MS.
Related Publications
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
January 2011,
Multiple sclerosis (Houndmills, Basingstoke, England),
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
June 2000,
Neuroreport,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
January 2000,
European neurology,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
June 2013,
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
August 2007,
Annals of neurology,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
December 2015,
Alzheimer's & dementia : the journal of the Alzheimer's Association,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
January 2013,
Neuro endocrinology letters,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
January 2016,
Oman medical journal,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
October 1977,
Neurology,
E Bryld, and
I Zeeberg, and
A Gjerris, and
L Werdelin, and
J F Rehfeld
June 2010,
Experimental neurology,
